• +1-646-491-9876
    • +91-20-67278686

    Search

    Global CNS Therapeutics Market Research Report 2016

    Global CNS Therapeutics Market Research Report 2016

    • Report Code ID: RW0001411289
    • Category Pharmaceuticals
    • No. of Pages 112
    • Publication Month Sep-16
    • Publisher Name QY Research
    Notes:
    Production, means the output of CNS Therapeutics
    Revenue, means the sales value of CNS Therapeutics

    This report studies CNS Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
    Pfizer, Inc. (USA)
    Johnson & Johnson (USA)
    Bristol-Myers Squibb (USA)
    Dainippon Sumitomo Pharma Co., Ltd. (Japan)
    Eisai Co., Ltd. (Japan)
    Eli Lilly and Co. (USA)
    F. Hoffmann-La Roche Ltd. (Switzerland)
    Fabre-Kramer Pharmaceuticals, Inc. (USA)
    BIAL Group (Portugal)
    Boehringer Ingelheim GmbH (Germany)
    Sanofi S.A (France)
    Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of CNS Therapeutics in these regions, from 2011 to 2021 (forecast), like
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
    Anti-Alzheimer's Drugs
    Anti-Parkinson's Drugs
    Anti-Epilepsy Drugs
    Pain Management Drugs
    Anti-Psychotics Drugs
    Split by application, this report focuses on consumption, market share and growth rate of CNS Therapeutics in each application, can be divided into
    Application 1
    Application 2
    Application 3
    Table of Contents

    Global CNS Therapeutics Market Research Report 2016
    1 CNS Therapeutics Market Overview
    1.1 Product Overview and Scope of CNS Therapeutics
    1.2 CNS Therapeutics Segment by Type
    1.2.1 Global Production Market Share of CNS Therapeutics by Type in 2015
    1.2.2 Anti-Alzheimer's Drugs
    1.2.3 Anti-Parkinson's Drugs
    1.2.4 Anti-Epilepsy Drugs
    1.2.5 Pain Management Drugs
    1.2.6 Anti-Psychotics Drugs
    1.3 CNS Therapeutics Segment by Application
    1.3.1 CNS Therapeutics Consumption Market Share by Application in 2015
    1.3.2 Application 1
    1.3.3 Application 2
    1.3.4 Application 3
    1.4 CNS Therapeutics Market by Region
    1.4.1 North America Status and Prospect (2011-2021)
    1.4.2 Europe Status and Prospect (2011-2021)
    1.4.3 China Status and Prospect (2011-2021)
    1.4.4 Japan Status and Prospect (2011-2021)
    1.4.5 Southeast Asia Status and Prospect (2011-2021)
    1.4.6 India Status and Prospect (2011-2021)
    1.5 Global Market Size (Value) of CNS Therapeutics (2011-2021)

    2 Global CNS Therapeutics Market Competition by Manufacturers
    2.1 Global CNS Therapeutics Production and Share by Manufacturers (2015 and 2016)
    2.2 Global CNS Therapeutics Revenue and Share by Manufacturers (2015 and 2016)
    2.3 Global CNS Therapeutics Average Price by Manufacturers (2015 and 2016)
    2.4 Manufacturers CNS Therapeutics Manufacturing Base Distribution, Sales Area and Product Type
    2.5 CNS Therapeutics Market Competitive Situation and Trends
    2.5.1 CNS Therapeutics Market Concentration Rate
    2.5.2 CNS Therapeutics Market Share of Top 3 and Top 5 Manufacturers
    2.5.3 Mergers & Acquisitions, Expansion

    3 Global CNS Therapeutics Production, Revenue (Value) by Region (2011-2016)
    3.1 Global CNS Therapeutics Production and Market Share by Region (2011-2016)
    3.2 Global CNS Therapeutics Revenue (Value) and Market Share by Region (2011-2016)
    3.3 Global CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
    3.4 North America CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
    3.5 Europe CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
    3.6 China CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
    3.7 Japan CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
    3.8 Southeast Asia CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
    3.9 India CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)

    4 Global CNS Therapeutics Supply (Production), Consumption, Export, Import by Regions (2011-2016)
    4.1 Global CNS Therapeutics Consumption by Regions (2011-2016)
    4.2 North America CNS Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)
    4.3 Europe CNS Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)
    4.4 China CNS Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)
    4.5 Japan CNS Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)
    4.6 Southeast Asia CNS Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)
    4.7 India CNS Therapeutics Production, Consumption, Export, Import by Regions (2011-2016)

    5 Global CNS Therapeutics Production, Revenue (Value), Price Trend by Type
    5.1 Global CNS Therapeutics Production and Market Share by Type (2011-2016)
    5.2 Global CNS Therapeutics Revenue and Market Share by Type (2011-2016)
    5.3 Global CNS Therapeutics Price by Type (2011-2016)
    5.4 Global CNS Therapeutics Production Growth by Type (2011-2016)

    6 Global CNS Therapeutics Market Analysis by Application
    6.1 Global CNS Therapeutics Consumption and Market Share by Application (2011-2016)
    6.2 Global CNS Therapeutics Consumption Growth Rate by Application (2011-2016)
    6.3 Market Drivers and Opportunities
    6.3.1 Potential Applications
    6.3.2 Emerging Markets/Countries

    7 Global CNS Therapeutics Manufacturers Profiles/Analysis
    7.1 Pfizer, Inc. (USA)
    7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
    7.1.2 CNS Therapeutics Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
    7.1.3 Pfizer, Inc. (USA) CNS Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
    7.1.4 Main Business/Business Overview
    7.2 Johnson & Johnson (USA)
    7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
    7.2.2 CNS Therapeutics Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
    7.2.3 Johnson & Johnson (USA) CNS Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
    7.2.4 Main Business/Business Overview
    7.3 Bristol-Myers Squibb (USA)
    7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
    7.3.2 CNS Therapeutics Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
    7.3.3 Bristol-Myers Squibb (USA) CNS Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
    7.3.4 Main Business/Business Overview
    7.4 Dainippon Sumitomo Pharma Co., Ltd. (Japan)
    7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
    7.4.2 CNS Therapeutics Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
    7.4.3 Dainippon Sumitomo Pharma Co., Ltd. (Japan) CNS Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
    7.4.4 Main Business/Business Overview
    7.5 Eisai Co., Ltd. (Japan)
    7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
    7.5.2 CNS Therapeutics Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
    7.5.3 Eisai Co., Ltd. (Japan) CNS Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
    7.5.4 Main Business/Business Overview
    7.6 Eli Lilly and Co. (USA)
    7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
    7.6.2 CNS Therapeutics Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
    7.6.3 Eli Lilly and Co. (USA) CNS Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
    7.6.4 Main Business/Business Overview
    7.7 F. Hoffmann-La Roche Ltd. (Switzerland)
    7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
    7.7.2 CNS Therapeutics Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
    7.7.3 F. Hoffmann-La Roche Ltd. (Switzerland) CNS Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
    7.7.4 Main Business/Business Overview
    7.8 Fabre-Kramer Pharmaceuticals, Inc. (USA)
    7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
    7.8.2 CNS Therapeutics Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
    7.8.3 Fabre-Kramer Pharmaceuticals, Inc. (USA) CNS Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
    7.8.4 Main Business/Business Overview
    7.9 BIAL Group (Portugal)
    7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
    7.9.2 CNS Therapeutics Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
    7.9.3 BIAL Group (Portugal) CNS Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
    7.9.4 Main Business/Business Overview
    7.10 Boehringer Ingelheim GmbH (Germany)
    7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
    7.10.2 CNS Therapeutics Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
    7.10.3 Boehringer Ingelheim GmbH (Germany) CNS Therapeutics Production, Revenue, Price and Gross Margin (2015 and 2016)
    7.10.4 Main Business/Business Overview
    7.11 Sanofi S.A (France)

    8 CNS Therapeutics Manufacturing Cost Analysis
    8.1 CNS Therapeutics Key Raw Materials Analysis
    8.1.1 Key Raw Materials
    8.1.2 Price Trend of Key Raw Materials
    8.1.3 Key Suppliers of Raw Materials
    8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
    8.2.1 Raw Materials
    8.2.2 Labor Cost
    8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of CNS Therapeutics

    9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 CNS Therapeutics Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of CNS Therapeutics Major Manufacturers in 2015
    9.4 Downstream Buyers

    10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
    10.1.1 Direct Marketing
    10.1.2 Indirect Marketing
    10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
    10.2.1 Pricing Strategy
    10.2.2 Brand Strategy
    10.2.3 Target Client
    10.3 Distributors/Traders List

    11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
    11.1.1 Substitutes Threat
    11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

    12 Global CNS Therapeutics Market Forecast (2016-2021)
    12.1 Global CNS Therapeutics Production, Revenue Forecast (2016-2021)
    12.2 Global CNS Therapeutics Production, Consumption Forecast by Regions (2016-2021)
    12.3 Global CNS Therapeutics Production Forecast by Type (2016-2021)
    12.4 Global CNS Therapeutics Consumption Forecast by Application (2016-2021)
    12.5 CNS Therapeutics Price Forecast (2016-2021)

    13 Research Findings and Conclusion

    14 Appendix
    Author List
    Disclosure Section
    Research Methodology
    Data Source
    China Disclaimer




    List of Tables and Figures

    Figure Picture of CNS Therapeutics
    Figure Global Production Market Share of CNS Therapeutics by Type in 2015
    Figure Product Picture of Anti-Alzheimer's Drugs
    Table Major Manufacturers of Anti-Alzheimer's Drugs
    Figure Product Picture of Anti-Parkinson's Drugs
    Table Major Manufacturers of Anti-Parkinson's Drugs
    Figure Product Picture of Anti-Epilepsy Drugs
    Table Major Manufacturers of Anti-Epilepsy Drugs
    Figure Product Picture of Pain Management Drugs
    Table Major Manufacturers of Pain Management Drugs
    Figure Product Picture of Anti-Psychotics Drugs
    Table Major Manufacturers of Anti-Psychotics Drugs
    Table CNS Therapeutics Consumption Market Share by Application in 2015
    Figure Application 1 Examples
    Figure Application 2 Examples
    Figure Application 3 Examples
    Figure North America CNS Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
    Figure Europe CNS Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
    Figure China CNS Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
    Figure Japan CNS Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
    Figure Southeast Asia CNS Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
    Figure India CNS Therapeutics Revenue (Million USD) and Growth Rate (2011-2021)
    Figure Global CNS Therapeutics Revenue (Million UDS) and Growth Rate (2011-2021)
    Table Global CNS Therapeutics Production of Key Manufacturers (2015 and 2016)
    Table Global CNS Therapeutics Production Share by Manufacturers (2015 and 2016)
    Figure 2015 CNS Therapeutics Production Share by Manufacturers
    Figure 2016 CNS Therapeutics Production Share by Manufacturers
    Table Global CNS Therapeutics Revenue (Million USD) by Manufacturers (2015 and 2016)
    Table Global CNS Therapeutics Revenue Share by Manufacturers (2015 and 2016)
    Table 2015 Global CNS Therapeutics Revenue Share by Manufacturers
    Table 2016 Global CNS Therapeutics Revenue Share by Manufacturers
    Table Global Market CNS Therapeutics Average Price of Key Manufacturers (2015 and 2016)
    Figure Global Market CNS Therapeutics Average Price of Key Manufacturers in 2015
    Table Manufacturers CNS Therapeutics Manufacturing Base Distribution and Sales Area
    Table Manufacturers CNS Therapeutics Product Type
    Figure CNS Therapeutics Market Share of Top 3 Manufacturers
    Figure CNS Therapeutics Market Share of Top 5 Manufacturers
    Table Global CNS Therapeutics Production by Regions (2011-2016)
    Figure Global CNS Therapeutics Production and Market Share by Regions (2011-2016)
    Figure Global CNS Therapeutics Production Market Share by Regions (2011-2016)
    Figure 2015 Global CNS Therapeutics Production Market Share by Regions
    Table Global CNS Therapeutics Revenue by Regions (2011-2016)
    Table Global CNS Therapeutics Revenue Market Share by Regions (2011-2016)
    Table 2015 Global CNS Therapeutics Revenue Market Share by Regions
    Table Global CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
    Table North America CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
    Table Europe CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
    Table China CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
    Table Japan CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
    Table Southeast Asia CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
    Table India CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
    Table Global CNS Therapeutics Consumption Market by Regions (2011-2016)
    Table Global CNS Therapeutics Consumption Market Share by Regions (2011-2016)
    Figure Global CNS Therapeutics Consumption Market Share by Regions (2011-2016)
    Figure 2015 Global CNS Therapeutics Consumption Market Share by Regions
    Table North America CNS Therapeutics Production, Consumption, Import & Export (2011-2016)
    Table Europe CNS Therapeutics Production, Consumption, Import & Export (2011-2016)
    Table China CNS Therapeutics Production, Consumption, Import & Export (2011-2016)
    Table Japan CNS Therapeutics Production, Consumption, Import & Export (2011-2016)
    Table Southeast Asia CNS Therapeutics Production, Consumption, Import & Export (2011-2016)
    Table India CNS Therapeutics Production, Consumption, Import & Export (2011-2016)
    Table Global CNS Therapeutics Production by Type (2011-2016)
    Table Global CNS Therapeutics Production Share by Type (2011-2016)
    Figure Production Market Share of CNS Therapeutics by Type (2011-2016)
    Figure 2015 Production Market Share of CNS Therapeutics by Type
    Table Global CNS Therapeutics Revenue by Type (2011-2016)
    Table Global CNS Therapeutics Revenue Share by Type (2011-2016)
    Figure Production Revenue Share of CNS Therapeutics by Type (2011-2016)
    Figure 2015 Revenue Market Share of CNS Therapeutics by Type
    Table Global CNS Therapeutics Price by Type (2011-2016)
    Figure Global CNS Therapeutics Production Growth by Type (2011-2016)
    Table Global CNS Therapeutics Consumption by Application (2011-2016)
    Table Global CNS Therapeutics Consumption Market Share by Application (2011-2016)
    Figure Global CNS Therapeutics Consumption Market Share by Application in 2015
    Table Global CNS Therapeutics Consumption Growth Rate by Application (2011-2016)
    Figure Global CNS Therapeutics Consumption Growth Rate by Application (2011-2016)
    Table Pfizer, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Pfizer, Inc. (USA) CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
    Figure Pfizer, Inc. (USA) CNS Therapeutics Market Share (2011-2016)
    Table Johnson & Johnson (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Johnson & Johnson (USA) CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
    Figure Johnson & Johnson (USA) CNS Therapeutics Market Share (2011-2016)
    Table Bristol-Myers Squibb (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Bristol-Myers Squibb (USA) CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
    Figure Bristol-Myers Squibb (USA) CNS Therapeutics Market Share (2011-2016)
    Table Dainippon Sumitomo Pharma Co., Ltd. (Japan) Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Dainippon Sumitomo Pharma Co., Ltd. (Japan) CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
    Figure Dainippon Sumitomo Pharma Co., Ltd. (Japan) CNS Therapeutics Market Share (2011-2016)
    Table Eisai Co., Ltd. (Japan) Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Eisai Co., Ltd. (Japan) CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
    Figure Eisai Co., Ltd. (Japan) CNS Therapeutics Market Share (2011-2016)
    Table Eli Lilly and Co. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Eli Lilly and Co. (USA) CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
    Figure Eli Lilly and Co. (USA) CNS Therapeutics Market Share (2011-2016)
    Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table F. Hoffmann-La Roche Ltd. (Switzerland) CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
    Figure F. Hoffmann-La Roche Ltd. (Switzerland) CNS Therapeutics Market Share (2011-2016)
    Table Fabre-Kramer Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Fabre-Kramer Pharmaceuticals, Inc. (USA) CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
    Figure Fabre-Kramer Pharmaceuticals, Inc. (USA) CNS Therapeutics Market Share (2011-2016)
    Table BIAL Group (Portugal) Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table BIAL Group (Portugal) CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
    Figure BIAL Group (Portugal) CNS Therapeutics Market Share (2011-2016)
    Table Boehringer Ingelheim GmbH (Germany) Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Boehringer Ingelheim GmbH (Germany) CNS Therapeutics Production, Revenue, Price and Gross Margin (2011-2016)
    Figure Boehringer Ingelheim GmbH (Germany) CNS Therapeutics Market Share (2011-2016)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of CNS Therapeutics
    Figure Manufacturing Process Analysis of CNS Therapeutics
    Figure CNS Therapeutics Industrial Chain Analysis
    Table Raw Materials Sources of CNS Therapeutics Major Manufacturers in 2015
    Table Major Buyers of CNS Therapeutics
    Table Distributors/Traders List
    Figure Global CNS Therapeutics Production and Growth Rate Forecast (2016-2021)
    Figure Global CNS Therapeutics Revenue and Growth Rate Forecast (2016-2021)
    Table Global CNS Therapeutics Production Forecast by Regions (2016-2021)
    Table Global CNS Therapeutics Consumption Forecast by Regions (2016-2021)
    Table Global CNS Therapeutics Production Forecast by Type (2016-2021)
    Table Global CNS Therapeutics Consumption Forecast by Application (2016-2021)

    Request for Sample

    Report Url http://www.reportsweb.com//global-cns-therapeutics-market-research-report-2016&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url http://www.reportsweb.com//global-cns-therapeutics-market-research-report-2016&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url http://www.reportsweb.com//global-cns-therapeutics-market-research-report-2016&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments